There is no panel matching the key "Alert"
There is no panel matching the key "MicroAlert"
Richard P. Cutts

Richard P. Cutts, MD

Specialties: Resident and Surgery
No Patient Experience Reviews – Why Not?

We do not collect individual feedback for this type of clinician.

Main Location

Profile

Personal Interests

Dr. Cutts was born and raised in Winnipeg, Manitoba, Canada. He moved to the U.S. to attend college, and met his wife, Jacquie, when he applied to go to Uganda for a year with her non-profit organization. They have three spunky children, and as a family enjoy camping, boating, fishing and playing games. In his limited spare time outside of family, Richard enjoys sports, both watching and playing.

After residency, Richard plans on practicing general surgery while prioritizing international work to help in-country providers meet the growing demands of global surgical needs.

Education and Training

College
Brigham Young University
Medical School
Emory University School of Medicine
Residency
Gundersen Medical Foundation

Professional Memberships

  • American College of Surgeons (ACS)
  • Association for Academic Surgery (AAS)
  • Wisconsin Surgical Society (WSS)

Published Works

  • Xu-Monette ZY, Li L, Byrd JC, et al. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Blood. 2016;128(26):3083-3100. doi: 10.1182/blood-2016-05-715094 [doi]
  • Chen J, Xu-Monette ZY, Deng L, et al. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget. 2015;6(8):5597-5614. doi: 3343 [pii]
  • Liu Z, Xu-Monette ZY, Cao X, et al. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy. Mod Pathol. 2015;28(10):1297-1314. doi: 10.1038/modpathol.2015.94 [doi]
  • Xu-Monette ZY, Dabaja BS, Wang X, et al. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2015;28(12):1555-1573. doi: 10.1038/modpathol.2015.118 [doi]
  • Xu-Monette ZY, Tu M, Jabbar KJ, et al. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in western countries. Oncotarget. 2015. doi: 3479 [pii]
  • Xu-Monette ZY, Tu M, Jabbar KJ, et al. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries. Oncotarget. 2015;6(8):5615-5633. doi: 3479 [pii]
  • Ok CY, Chen J, Xu-Monette ZY, et al. Clinical implications of phosphorylated STAT3 expression in de novo diffuse large B-cell lymphoma. Clin Cancer Res. 2014;20(19):5113-5123. doi: 10.1158/1078-0432.CCR-14-0683 [doi]
  • Ok CY, Li L, Xu-Monette ZY, et al. Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res. 2014;20(9):2338-2349. doi: 10.1158/1078-0432.CCR-13-3157 [doi]
  • Ok CY, Xu-Monette ZY, Tzankov A, et al. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer. 2014;120(12):1818-1829. doi: 10.1002/cncr.28664 [doi]
  • Tzankov A, Xu-Monette ZY, Gerhard M, et al. Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol. 2014;27(7):958-971. doi: 10.1038/modpathol.2013.214 [doi]
Love + Medicine

Every day, Gundersen Health System staff deliver great medicine plus a little something extra—we call it Love + Medicine.

Share Your Story